Welcome to YLOAN.COM
yloan.com » Marketing » Aarkstore Enterprise---pharmaceutical Product Relaunch: Preserving Market Share Through Line Extensi
Marketing Advertising Branding Careers-Employment Change-Management Customer Service Entrepreneurialism Ethics Marketing-Direct Negotiation Outsourcing PR Presentation Resumes-Cover-Letters Sales Sales-Management Sales-Teleselling Sales-Training Strategic-Planning Team-Building Top7-or-Top10-Tips Workplace-Communication aarkstore corporate advantages development collection global purchasing rapidshare grinding wildfire shipping trading economy wholesale agency florida attorney strategy county consumer bills niche elliptical

Aarkstore Enterprise---pharmaceutical Product Relaunch: Preserving Market Share Through Line Extensi

Product teams must begin their relaunch planning early to incorporate it into a strong overall lifecycle management strategy

. As product teams enter Phase 2 of development for their initial launch, they are often planning their relaunch strategies for years later. Early planning is one of the key factors in making a product relaunch successful.

We analyzed the relaunch strategies outlined in this study into two categories: Line Extensions and New Market Entries. Each line extension or new market entry strategy profiled in this study includes a detailed analysis of:

* Implementation costs

* Time to implement


* Strategy outcome in terms of revenue

* Market share protection gained from implementing the tactic

Product relaunch success is a combination of timing, investment and the science behind each drug. A drug manufacturer must first identify whether a compound may be a viable relaunch candidate. Then, the manufacturer must determine the level of investment necessary to bring a relaunch product to market. The next, and perhaps most important, step is for the product team to determine when to relaunch the drug.

Additional Information

Companies Included in Report

Abbott Laboratories, Alexion, Allergan, Astellas Pharma, AstraZeneca, Bristol-Myers Squibb, Biogen, Biovail, Center for Development and International Cooperation, Cyclacel Pharmaceuticals, Galderma, Genentech, GlaxoSmithKline, Guebet, IMB Healthcare Consultants, Institute of Clinical Research, Johnson & Johnson, KKI Technology, Merck & Co, Novartis, NPS Pharma, Onyx Pharmaceuticals, Pfizer, Pharma Green Egypt, Roemmers Centro America, Strategyx, Syncom Pharmaceutical, TEVA and UCB Pharma.

For more information please contact :

http://www.aarkstore.com/reports/Pharmaceutical-Product-Relaunch-Preserving-Market-Share-through-Line-Extension-and-New-Market-Entry-Strategies-6901.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

by: Aarkstore Enterprise
Aarkstore Enterprise---early-stage Pharmaceutical Marketing Budgets: Preparing For Product Launch Aarkstore Enterprise---post-launch Brand Marketing In Select Affiliate Markets How to Launch an Email Marketing Campaign Consumer Mailing Lists A Significant Necessity For E Marketing The Perils Of Viral Video Marketing The Five Effective Avenues Of Marketing Your Website Observation: Domestic Appliances Corps Mobile Swallow Small Profit Can The Small Investor Surive In This Market? Tv Industry "in Weakening The Strong Korean Won," The Market Structure Still Variable The Dun & Bradstreet Corporation - Swot Analysis - Market Research Reports On Aarkstore Enterprise States United States To Seize The Market Cheap Storm Ahead Of Golden Week Preview The Key Element To Becoming A Successful Multi-level Marketing Professional Social Media Marketing for Chiropractors 101
print
www.yloan.com guest:  register | login | search IP(216.73.216.60) California / Anaheim Processed in 0.016903 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 34 , 2171, 66,
Aarkstore Enterprise---pharmaceutical Product Relaunch: Preserving Market Share Through Line Extensi Anaheim